BEIJING, Oct. 28, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release third quarter 2013 financial results on Tuesday, November 5, 2013 after the market closes.
The Company's management will hold a conference call at 7:30 a.m. ET on Wednesday, November 6, 2013, which is 8:30 p.m., Beijing Time on November 6, 2013, to discuss third quarter 2013 results. Listeners may access the call by dialing: US:
+1 866 652 5200International:
+1 412 317 6060Hong Kong:
06 800 20175China:
400 120 1203Passcode:
10036364A telephone replay of the call will be available after the conclusion of the conference all through 9:00 a.m., Eastern Time on November 14, 2013. The dial-in details are:
+1 877 344 7529International:
+1 412 317 0088Passcode:
10036364A live and archived webcast of the conference call will be available through the Company's investor relations website at http://chinabiologic.investorroom.com/.
About China Biologic Products, Inc.China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and other healthcare facilities in China. For additional information, please see the Company's website www.chinabiologic.com.
Contact:China Biologic Products, Inc.
Mr. Ming Yin
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
|SOURCE China Biologic Products, Inc.|
Copyright©2012 PR Newswire.
All rights reserved